Clinical Trials Directory

Trials / Completed

CompletedNCT01800877

Optimal VAsopressor titraTION Pilot Randomized Controlled Trial

Optimal Vasopressor Titration Pilot Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Francois Lamontagne · Academic / Other
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to determine if it is better to give vasopressors to patients to maintain a higher blood pressure target versus a lower blood pressure target. This study is important because the information we find out will help us know how best to administer vasopressors in patients with shock in the ICU.

Detailed description

Patients who are admitted to the intensive care unit (ICU) commonly suffer from shock, a condition that causes life-threatening low blood pressure. Low blood pressure makes it difficult for the body to deliver blood to all of its organs. The standard treatment doctors in the ICU use for their patients is to give medications that help increase blood pressure. These medications are called vasopressors. There can be side effects related to using vasopressors. The purpose of this research study is to determine if it is better to give vasopressors to patients to maintain a higher blood pressure target versus a lower blood pressure target. This study is important because the information we find out will help us know how best to administer vasopressors in patients with shock in the ICU.

Conditions

Interventions

TypeNameDescription
DRUGVasopressors

Timeline

Start date
2013-04-01
Primary completion
2014-12-01
Completion
2015-02-01
First posted
2013-02-28
Last updated
2019-03-12
Results posted
2019-03-12

Locations

10 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01800877. Inclusion in this directory is not an endorsement.